NASDAQ · Medical - Care Facilities

BTMD (BTMD) Stock

$1.55 -8.28% NASDAQ: BTMD Healthcare

Valuation

MetricValue
Price$1.55
Market Cap$68.37M
P/E Ratio10.07
P/B Ratio-0.74
P/S Ratio0.41
EPS (TTM)$0.00
52-Week High$3.62
52-Week Low$1.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.25%
ROA5.76%
ROCE20.61%
Gross Margin20.31%
Operating Margin20.31%
Net Margin3.19%
Debt/Equity-1.96
Current Ratio1.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$139.0M$165.0M$185.0M$197.0M$192.0M
Operating Profit$35.0M$-61.0M$29.0M$32.0M$36.0M
Net Profit$33.0M$-1.0M$3.0M$3.0M$27.0M
EPS$4.31$-0.12$0.13$0.09$0.74
Op Margin24.8%-36.8%15.5%16.0%18.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$112.0M$155.0M$122.0M$108.0M
Total Liabilities$50.0M$170.0M$192.0M$225.0M$158.0M
Cash$27.0M$79.0M$89.0M$39.0M$24.0M
Borrowings$37.0M$120.0M$115.0M$111.0M$110.0M

Latest News

How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations Simply Wall St. · Jun 6, 2026 Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer Business Wire · Jun 1, 2026 biote Corp. Q1 2026 Earnings Call Summary Moby · May 7, 2026 biote Q1 Earnings Call Highlights MarketBeat · May 6, 2026 Biote (BTMD) Q1 2026 Earnings Call Transcript Motley Fool · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$34.0M$-9.0M$27.0M$45.0M$35.0M
Investing Cash Flow$-8.0M$-4.0M$-5.0M$-25.0M$-12.0M
Financing Cash Flow$-4.0M$-8.0M$0$-65.0M$-41.0M
Net Cash Flow$10.0M$52.0M$10.0M$-50.0M$-15.0M
Free Cash Flow$30.0M$-11.0M$24.0M$39.0M$30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA8.18
FCF Yield26.40%
Quick Ratio0.82
Interest Coverage1.58
Return 1Y-42.77%
Return 3Y-67.60%
Return 5Y-76.80%

Ownership

Insiders Held10.39%
Institutions Held67.17%
Institutions Float Held74.96%
Institutional HolderSharesReport Date
325 Capital Llc4,548,1272026-03-31
Bandera Partners LLC2,065,4822026-03-31
Blackrock Inc.1,739,2442026-03-31
Vanguard Capital Management LLC1,113,8552026-03-31
Acadian Asset Management. LLC697,8552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABOS $3.09 -0.32% -1.88 $223.18M 0.00%
ACTU $1.37 +5.38% -1.46 $32.78M 0.00%
ANIK $21.00 -2.55% -19.58 $281.04M 0.00%
INO $1.36 +0.00% -2.73 $93.97M 0.00%
JYNTThe Joint Corp. $8.28 +0.49% 45.89 $118.03M 0.00%

About BTMD

BTMD is led by CEO Bret Christensen, employs 217 people, headquartered in US, publicly traded since 2021.

BTMD stock trades at $1.55 with a market capitalization of $68.37M. The stock is valued at a price-to-earnings (P/E) ratio of 10.07, price-to-book of -0.74, price-to-sales of 0.41. Over the past 52 weeks the stock has ranged between $1.27 and $3.62, and currently trades 57.2% below its 52-week high.

On profitability, BTMD generates a return on equity (ROE) of -9.25%, return on capital employed of 20.61%, an operating margin of 20.31%, a net profit margin of 3.19%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.50 -0.05% JNJ Drug Manufacturers - General $278.43 +1.17% ABBV Drug Manufacturers - General $260.30 -0.54% MRK Drug Manufacturers - General $152.34 +0.46% UNH Medical - Healthcare Plans $400.94 +0.32% NVS Drug Manufacturers - General $163.09 +0.39% AZN Drug Manufacturers - General $164.77 +1.94% AMGN Drug Manufacturers - General $444.12 +0.29% TMO Medical - Diagnostics & Research $618.43 +1.63% NVO Biotechnology $47.51 +1.58% ABT Medical - Devices $108.80 -1.51% GILD Drug Manufacturers - General $151.22 +1.08%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides